Detection of Micrometastatic Cells in Breast Cancer by RT-pCR for the Mammaglobin Gene
Overview
Authors
Affiliations
The detection of circulating cancer cells in the bone marrow (BM) and peripheral blood (PB) of patients with solid tumors may be useful for disease staging. To this aim, we evaluated the expression of the mammaglobin gene by reverse transcriptase polymerase chain reaction (RT-PCR) in 60 patients with breast cancer. Moreover, several controls were examined to test the specificity of this marker. The positive cases included 23.6% of the patients with and 9% of those without metastasis. Only 4/60 negative controls analyzed were positive by PCR. Our results show high specificity and a good correlation with disease status.
Breuninger S, Stangl S, Werner C, Sievert W, Lobinger D, Foulds G Front Oncol. 2018; 8:497.
PMID: 30443493 PMC: 6223102. DOI: 10.3389/fonc.2018.00497.
Sampling circulating tumor cells for clinical benefits: how frequent?.
Leong S, Tan K, Chua H, Tan D, Fareda D, Osmany S J Hematol Oncol. 2015; 8:75.
PMID: 26108208 PMC: 4488127. DOI: 10.1186/s13045-015-0174-9.
Human mammaglobin in breast cancer: a brief review of its clinical utility.
Al Joudi F Indian J Med Res. 2014; 139(5):675-85.
PMID: 25027076 PMC: 4140031.
Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.
Markiewicz A, Ksiazkiewicz M, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Szade J PLoS One. 2014; 9(4):e93901.
PMID: 24709997 PMC: 3977989. DOI: 10.1371/journal.pone.0093901.
Detecting circulating tumor cells: current challenges and new trends.
Hong B, Zu Y Theranostics. 2013; 3(6):377-94.
PMID: 23781285 PMC: 3677409. DOI: 10.7150/thno.5195.